Antigen-Specific Tolerizing Immunotherapy Promising in Rheumatoid Arthritis
Antigen-specific tolerizing immunotherapy may have therapeutic potential in rheumatoid arthritis.
All articles by Rheumatology Advisor Contributing Writer
Disease Burden of Serious Infections Increased in Sjögren Syndrome
Study authors assessed the incidence, time-trends, and outcomes of serious infections in Sjögren syndrome.
Comparative Performance of Sodium-Glucose Cotransporter-2 Inhibitors in Reducing Gout in Type 2 Diabetes
Researchers compared the beneficial effect of sodium-glucose cotransporter-2 (SGLT2) inhibitors on gout risk in patients with type 2 diabetes.
Assessing the Long-Term Safety and Efficacy of Tocilizumab in Systemic Sclerosis
The long-term safety and efficacy of tocilizumab in patients with systemic sclerosis were assessed in an open-label study.
Hypothyroidism Associated With Different Forms of ANCA-Associated Vasculitis
Researchers assessed thyroid disease risk between the different forms of ANCA-associated vasculitis (AAV), and compared the clinical features of AAV in patients with and without thyroid disease.
Aspirin Plus Heparin May Prevent Recurrent Miscarriage in Women With Antiphospholipid Syndrome
Researchers compared and evaluated pharmacologic interventions for the prevention of recurrent miscarriage in women with antiphospholipid syndrome.
Researchers Report Study Design and 2-Year Data From RA BIODAM Cohort
The research design of RA BIODAM and study population’s clinical characteristics over 2 years of follow-up were published in an initial report.
Genetics, Environment, and Lifestyle: How Does Each Affect Risk for Rheumatoid Arthritis?
Various combinations of genes, environmental factors, and chance may affect early immune activation and symptom onset in rheumatoid arthritis.
Population‐Based Reports of National Rheumatoid Arthritis Care Performance Measures
Researchers assessed nationally endorsed performance measures for rheumatoid arthritis care using population-based administrative data.
Long-Term Effects of Rituximab vs TNFis in RA-Associated Bronchiectasis
The majority of patients with rheumatoid arthritis-associated bronchiectasis treated with rituximab have a satisfactory safety profile.
-
Loading...
-
Loading...
Next post in Rheumatoid Arthritis Advisor
